Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Harrison

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Innate Immunity|August 28, 2018
Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic ApplicationsDani A C Heesterbeek, Mathieu L Angelier, Richard A Harrison, et al.
Immunology|June 16, 2025
CD59, Disulphide-Locked Human C9 and Horse C9 Inhibit Human Membrane Attack Complex Assembly by Similar MechanismsRebekah S Cooke, Bradley A Spicer, Richard A Harrison, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 16, 2003
Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human bloodCarsten Schröder, Steffen Pfeiffer, Guosheng Wu, et al.
American Journal of Respiratory and Critical Care Medicine|September 8, 2020
Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19Wioleta M Zelek, Jade Cole, Mark J Ponsford, et al.
Space Weather : the International Journal of Research & Applications|December 2, 2021
Evaluation of CME Arrival Prediction Using Ensemble Modeling Based on Heliospheric Imaging ObservationsTanja Amerstorfer, Jürgen Hinterreiter, Martin A Reiss, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?Suzannah Mawdsley, Rob Glynne-Jones, Juliet Grainger, et al.
Journal of Medicinal Chemistry|February 20, 2020
Discovery of 4-((2<i>S</i>,4<i>S</i>)-4-Ethoxy-1-((5-methoxy-7-methyl-1<i>H</i>-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated DiseasesNello Mainolfi, Takeru Ehara, Rajeshri G Karki, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Innate Immunity|August 28, 2018
Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic ApplicationsDani A C Heesterbeek, Mathieu L Angelier, Richard A Harrison, et al.
Immunology|June 16, 2025
CD59, Disulphide-Locked Human C9 and Horse C9 Inhibit Human Membrane Attack Complex Assembly by Similar MechanismsRebekah S Cooke, Bradley A Spicer, Richard A Harrison, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 16, 2003
Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human bloodCarsten Schröder, Steffen Pfeiffer, Guosheng Wu, et al.
American Journal of Respiratory and Critical Care Medicine|September 8, 2020
Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19Wioleta M Zelek, Jade Cole, Mark J Ponsford, et al.
Space Weather : the International Journal of Research & Applications|December 2, 2021
Evaluation of CME Arrival Prediction Using Ensemble Modeling Based on Heliospheric Imaging ObservationsTanja Amerstorfer, Jürgen Hinterreiter, Martin A Reiss, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?Suzannah Mawdsley, Rob Glynne-Jones, Juliet Grainger, et al.
Journal of Medicinal Chemistry|February 20, 2020
Discovery of 4-((2<i>S</i>,4<i>S</i>)-4-Ethoxy-1-((5-methoxy-7-methyl-1<i>H</i>-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated DiseasesNello Mainolfi, Takeru Ehara, Rajeshri G Karki, et al.
Pageof 2